Literature DB >> 31512243

Pollen exposure weakens innate defense against respiratory viruses.

Stefanie Gilles1, Cornelia Blume2,3, Maria Wimmer1,4, Athanasios Damialis1, Laura Meulenbroek4,5, Mehmet Gökkaya1, Carolin Bergougnan1, Selina Eisenbart1, Nicklas Sundell6, Magnus Lindh6, Lars-Magnus Andersson6, Åslög Dahl7, Adam Chaker8, Franziska Kolek1, Sabrina Wagner1, Avidan U Neumann1, Cezmi A Akdis9,10, Johan Garssen4,5, Johan Westin6, Belinda Van't Land5,11, Donna E Davies2,3, Claudia Traidl-Hoffmann1,10.   

Abstract

BACKGROUND: Hundreds of plant species release their pollen into the air every year during early spring. During that period, pollen allergic as well as non-allergic patients frequently present to doctors with severe respiratory tract infections. Our objective was therefore to assess whether pollen may interfere with antiviral immunity.
METHODS: We combined data from real-life human exposure cohorts, a mouse model and human cell culture to test our hypothesis.
RESULTS: Pollen significantly diminished interferon-λ and pro-inflammatory chemokine responses of airway epithelia to rhinovirus and viral mimics and decreased nuclear translocation of interferon regulatory factors. In mice infected with respiratory syncytial virus, co-exposure to pollen caused attenuated antiviral gene expression and increased pulmonary viral titers. In non-allergic human volunteers, nasal symptoms were positively correlated with airborne birch pollen abundance, and nasal birch pollen challenge led to downregulation of type I and -III interferons in nasal mucosa. In a large patient cohort, numbers of rhinoviruspositive cases were correlated with airborne birch pollen concentrations.
CONCLUSION: The ability of pollen to suppress innate antiviral immunity, independent of allergy, suggests that high-risk population groups should avoid extensive outdoor activities when pollen and respiratory virus seasons coincide.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  antiviral response; lambda-interferones; nasal symptoms; nonallergenic pollen compounds; respiratory syncytial virus; rhinovirus

Mesh:

Substances:

Year:  2019        PMID: 31512243     DOI: 10.1111/all.14047

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  18 in total

1. 

Authors:  Stefanie Gilles; Athanasios Damialis; Claudia Traidl-Hoffmann
Journal:  Allergo J       Date:  2021-05-07

Review 2. 

Authors:  Jeroen Buters; Jose Oteros; Robert Gebauer; Katharina Heigl
Journal:  Allergo J       Date:  2020-05-08

3.  Anthropogenic climate change is worsening North American pollen seasons.

Authors:  William R L Anderegg; John T Abatzoglou; Leander D L Anderegg; Leonard Bielory; Patrick L Kinney; Lewis Ziska
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

4.  Synergistic health effects of air pollution, temperature, and pollen exposure: a systematic review of epidemiological evidence.

Authors:  Susan C Anenberg; Shannon Haines; Elizabeth Wang; Nicholas Nassikas; Patrick L Kinney
Journal:  Environ Health       Date:  2020-12-07       Impact factor: 5.984

5.  Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe.

Authors:  Athanasios Damialis; Stefanie Gilles; Mikhail Sofiev; Viktoria Sofieva; Franziska Kolek; Daniela Bayr; Maria P Plaza; Vivien Leier-Wirtz; Sigrid Kaschuba; Lewis H Ziska; Leonard Bielory; László Makra; Maria Del Mar Trigo; Claudia Traidl-Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

Review 6.  Recent updates on COVID-19: A holistic review.

Authors:  Shweta Jakhmola; Omkar Indari; Dharmendra Kashyap; Nidhi Varshney; Annu Rani; Charu Sonkar; Budhadev Baral; Sayantani Chatterjee; Ayan Das; Rajesh Kumar; Hem Chandra Jha
Journal:  Heliyon       Date:  2020-12-11

7.  The need for Pan-European automatic pollen and fungal spore monitoring: A stakeholder workshop position paper.

Authors:  Fiona Tummon; Lucas Alados Arboledas; Maira Bonini; Benjamin Guinot; Martin Hicke; Christophe Jacob; Vladimir Kendrovski; William McCairns; Eric Petermann; Vincent-Henri Peuch; Oliver Pfaar; Michaël Sicard; Branko Sikoparija; Bernard Clot
Journal:  Clin Transl Allergy       Date:  2021-05-02       Impact factor: 5.657

8.  Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.

Authors:  Hui Du; Xiang Dong; Jin-Jin Zhang; Yi-Yuan Cao; Mubeccel Akdis; Pei-Qi Huang; Hong-Wei Chen; Ying Li; Guang-Hui Liu; Cezmi A Akdis; Xiao-Xia Lu; Ya-Dong Gao
Journal:  Allergy       Date:  2020-09-03       Impact factor: 14.710

9.  Eleven faces of coronavirus disease 2019.

Authors:  Xiang Dong; Yi-Yuan Cao; Xiao-Xia Lu; Jin-Jin Zhang; Hui Du; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-04-06       Impact factor: 14.710

Review 10.  Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.

Authors:  Heimo Breiteneder; Ya-Qi Peng; Ioana Agache; Zuzana Diamant; Thomas Eiwegger; Wytske J Fokkens; Claudia Traidl-Hoffmann; Kari Nadeau; Robyn E O'Hehir; Liam O'Mahony; Oliver Pfaar; Maria J Torres; De-Yun Wang; Luo Zhang; Cezmi A Akdis
Journal:  Allergy       Date:  2020-09-30       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.